YSL-25408-38609
2 vaccinations
5 coded responses
14 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 371 / TN
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Registered in v-safe
-
2021-01-18
Dose 2 — Pfizer-BioNTech
- 2021-01-18
-
2021-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-01-21
Survey response — days 1–6 daily, dose 2MedDRA: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth — Feeling: Good · Site: Pain, SwellingFree text: The injection site redness was present yesterday (day 2 post injection) but is gone today. There is, however, a swollen area that remains slightly warm and is firm to the touch. It is very slightly tender.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Injection site swelling — Feeling: Good · Site: SwellingFree text: The injection site remains swollen/firm, but the diameter of the circular are is smaller and it is less warm.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Injection site induration — Feeling: GoodFree text: Firm area at site of injection, now about fingertip size, remains.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
- 2021-02-02
- 2021-02-08
-
2021-02-15
Survey response — day 28, dose 2MedDRA: Constipation, Medical counselling — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Constipation · Healthcare visit (other): After hours phone consultationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-22
- 2021-03-01
- 2021-04-19
- 2021-07-19
-
2021-08-03
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-01-18
Survey response — 12 months, dose 2MedDRA: Anxiety, Decreased appetite, Dizziness, Feeling cold, Heart rate increased, Palpitations — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Palpitations and dizziness, combined with a sense of dread/vulnerability, being unusually cold (but not feverish), no appetite. Several instances of pounding, rapid heartbeat.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-18
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-18 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-02-15 | Successful 2021-08-03 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-01-18 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): The injection site redness was present yesterday (day 2 post injection) but is gone today. There is, however, a swollen area that remains slightly warm and is firm to the touch. It is very slightly tender.
Systemic reaction (other): The injection site remains swollen/firm, but the diameter of the circular are is smaller and it is less warm.
Systemic reaction (other): Firm area at site of injection, now about fingertip size, remains.
Release 4 — day 28, dose 2
Release 10 — 12 months, dose 2
Symptoms: Palpitations and dizziness, combined with a sense of dread/vulnerability, being unusually cold (but not feverish), no appetite. Several instances of pounding, rapid heartbeat.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Constipation | ✓ | ✓ | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Feeling cold | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site induration | ✓ | ✓ | ✓ |
| SRO | Injection site nodule | ○ | ○ | ○ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release